AMPLIFI-1 pivotal trial launched to assess vein dilation system for distal AVF creation
Amplifi Vascular recently announced the successful initiation of the AMPLIFI-1 trial at Brigham and Women's Hospital in Boston, USA. The first North American patients...
Leading vascular access surgeons call for solutions to fibrin sheath formation on central venous...
Central venous catheters (CVCs) are a widely used form of dialysis access, yet for years the clinical community has avoided discussing how to improve...
Innovation is dead in vascular access? A CX 2026 debate with no winners
Innovation is dead in vascular access. That was the unenviable challenge Nicholas Inston (Birmingham, UK) took on at the 2026 Charing Cross (CX) Symposium...
CX 2026: FLEX FIRST AV registry reports out to 12 months
Flex Vascular has announced the presentation of 12-month results from the FLEX FIRST AV registry, a prospective, multicentre, real-world study evaluating the Flex vessel...
